article thumbnail

Gelteq IPO: Supporting Gel Technology for Oral Drug Delivery

XTalks

This regulatory strategy leverages bioequivalence studies to expedite approval, positioning Gelteq’s gel as an alternative to traditional oral delivery forms. In the pharmaceutical segment, Gelteq advances its lead product — a gel-based pain management therapy — through the US Food and Drug Administration (FDA)’s 505(b)(2) pathway.

article thumbnail

Cerelle vs Cerazette: Are they really the same?

Druggist

Both contraceptives contain the same active ingredient: desogestrel (75 micrograms), a female sex hormone (synthetic progestogen). Generic medicines must go through bioequivalence studies to show that generic medicine produces the same amount of active drug in the body. Alternative progesterone-only methods of contraception .